Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01080 |
| Species: | Homo sapiens |
| Position : | chr17:3466973-3468374 |
| Year: | 2021 |
| Title: | CRISPR Deletion of a SVA Retrotransposon Demonstrates Function as a cis-Regulatory Element at the TRPV1/TRPV3 Intergenic Region |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | chronic myeloid leukemia |
| PMID: | 33671852 |
| MONDO: | MONDO:0011998 |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | K562 |
| CVCL ID: | CVCL_0004 |
| Cell Type: | chronic myeloid leukemia cell |
| Cell Ontology ID: | CL:0001054 |
| Experiment Type: | Functional perturbation assay, Enhancer activity assay |
| High Throughput Method: | RNA-seq |
| Low Throughput Method: | CRISPR Knockout, CRISPRi, Luciferase Reporter Assay, RT-RT-qPCR |
| Target gene : | TRPV3 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01216 | chr17:3466973-3468374 | Embryonic Kidney | embryonic kidney cell | -- |